CLARITAS RX Trademark

Trademark Overview


On Wednesday, August 9, 2023, a trademark application was filed for CLARITAS RX with the United States Patent and Trademark Office. The USPTO has given the CLARITAS RX trademark a serial number of 98125249. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2024. This trademark is owned by CLARITAS RX INC.. The CLARITAS RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals
claritas rx

General Information


Serial Number98125249
Word MarkCLARITAS RX
Filing DateWednesday, August 9, 2023
Status700 - REGISTERED
Status DateTuesday, December 10, 2024
Registration Number7594009
Registration DateTuesday, December 10, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "CLARITAS RX" with the letter "C" and "R" capitalized; to the left of the wording appears a stylized image of a diamond.
Section 2(f) Limitation Statementas to "RX" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"RX"
Goods and ServicesSoftware as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 10, 2023
Primary Code042
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History


Party NameCLARITAS RX INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCLARITAS RX INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCLARITAS RX INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 9, 2024ASSIGNED TO EXAMINER
Saturday, August 12, 2023NEW APPLICATION ENTERED
Sunday, September 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, April 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 15, 2024NON-FINAL ACTION E-MAILED
Monday, July 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, August 29, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, August 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, June 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 15, 2024NON-FINAL ACTION WRITTEN
Thursday, August 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED